Ken Griffin Accolade, Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$9.22 - $15.02 $199,152 - $324,432	21,600 Added 60.0%	57,600 $603,000
Q4 2023 Feb 14, 2024	BUY	$6.5 - $12.85 $115,050 - $227,445	17,700 Added 96.72%	36,000 $432,000
Q3 2023 Nov 14, 2023	BUY	$10.45 - $15.02 $16,720 - $24,032	1,600 Added 9.58%	18,300 $193,000
Q2 2023 Aug 14, 2023	BUY	$10.52 - $16.06 $109,408 - $167,024	10,400 Added 165.08%	16,700 $224,000
Q1 2023 May 15, 2023	SELL	$7.32 - $14.38 $211,548 - $415,582	-28,900 Reduced 82.1%	6,300 $90,000

Q4 2022 Feb 14, 2023	SELL	$7.19 - $13.16 $13,661 - $25,004	-1,900 Reduced 5.12%	35,200 $274,000
Q3 2022 Nov 14, 2022	SELL	$0.0 - $12.8 $0 - $189,440	-14,800 Reduced 28.52%	37,100 $424,000

171

68.5M

163K

492K

Ticker ACCD
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 71,938,896
Market Cap $258M
Description
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.